A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients. [electronic resource]
Producer: 20170207Description: 7295-303 p. digitalISSN:- 1423-0380
- Adenocarcinoma -- drug therapy
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Camptothecin -- administration & dosage
- Cetuximab -- administration & dosage
- Codon -- genetics
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Female
- Fluorouracil -- administration & dosage
- Genes, erbB-1
- Genes, ras
- Humans
- Irinotecan
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Neoplasm Proteins -- antagonists & inhibitors
- Panitumumab
- Polymorphism, Single Nucleotide
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins p21(ras) -- genetics
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.